NCT00149877View on ClinicalTrials.gov

Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation

PHASE4CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

February 28, 2006

Conditions

Chronic Constipation

Interventions

DRUG

Tegaserod

Trial Locations (1)

4056

Novartis, Basel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY